ARS Pharmaceuticals, Inc. (SPRY) Retained Earnings

Annual Retained Earnings:

-$123.31M+$8.00M(+6.09%)
December 31, 2024

Summary

  • As of today, SPRY annual retained earnings is -$123.31 million, with the most recent change of +$8.00 million (+6.09%) on December 31, 2024.
  • During the last 3 years, SPRY annual retained earnings has fallen by -$81.05 million (-191.80%).
  • SPRY annual retained earnings is now -209.66% below its all-time high of -$39.82 million, reached on December 1, 2018.

Performance

SPRY Retained Earnings Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherSPRYbalance sheet metrics

Quarterly Retained Earnings:

-$253.28M-$51.15M(-25.31%)
September 30, 2025

Summary

  • As of today, SPRY quarterly retained earnings is -$253.28 million, with the most recent change of -$51.15 million (-25.31%) on September 30, 2025.
  • Over the past year, SPRY quarterly retained earnings has dropped by -$80.04 million (-46.20%).
  • SPRY quarterly retained earnings is now -297.07% below its all-time high of -$63.79 million, reached on December 1, 2019.

Performance

SPRY Quarterly Retained Earnings Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherSPRYbalance sheet metrics

Retained Earnings Formula

Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid

SPRY Retained Earnings Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1Y1 Year+6.1%-46.2%
3Y3 Years-191.8%-2.1%
5Y5 Years-93.3%-161.8%

SPRY Retained Earnings Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs Low
3Y3-Year-191.8%+6.1%-175.6%at low
5Y5-Year-191.8%+6.1%-175.6%at low
All-TimeAll-Time-209.7%+6.1%-297.1%at low

SPRY Retained Earnings History

DateAnnualQuarterly
Sep 2025
-
-$253.28M(-25.3%)
Jun 2025
-
-$202.13M(-28.5%)
Mar 2025
-
-$157.25M(-27.5%)
Dec 2024
-$123.31M(+6.1%)
-$123.31M(+28.8%)
Sep 2024
-
-$173.24M(-12.4%)
Jun 2024
-
-$154.11M(-8.8%)
Mar 2024
-
-$141.59M(-7.8%)
Dec 2023
-$131.30M(-70.7%)
-$131.30M(-5.8%)
Sep 2023
-
-$124.14M(-13.6%)
Jun 2023
-
-$109.27M(-18.9%)
Mar 2023
-
-$91.90M
DateAnnualQuarterly
Dec 2022
-$76.94M(-82.1%)
-
Sep 2022
-
-$248.14M(-7.8%)
Jun 2022
-
-$230.27M(-9.2%)
Mar 2022
-
-$210.84M(-13.2%)
Dec 2021
-$42.26M(+56.3%)
-
Dec 2021
-
-$186.21M(-14.4%)
Sep 2021
-
-$162.75M(-16.2%)
Jun 2021
-
-$140.10M(-21.2%)
Mar 2021
-
-$115.60M(-19.5%)
Dec 2020
-$96.73M(-51.7%)
-$96.73M(-51.7%)
Dec 2019
-$63.79M(-60.2%)
-$63.79M
Dec 2018
-$39.82M
-

FAQ

  • What is ARS Pharmaceuticals, Inc. annual retained earnings?
  • What is the all-time high annual retained earnings for ARS Pharmaceuticals, Inc.?
  • What is ARS Pharmaceuticals, Inc. annual retained earnings year-on-year change?
  • What is ARS Pharmaceuticals, Inc. quarterly retained earnings?
  • What is the all-time high quarterly retained earnings for ARS Pharmaceuticals, Inc.?
  • What is ARS Pharmaceuticals, Inc. quarterly retained earnings year-on-year change?

What is ARS Pharmaceuticals, Inc. annual retained earnings?

The current annual retained earnings of SPRY is -$123.31M

What is the all-time high annual retained earnings for ARS Pharmaceuticals, Inc.?

ARS Pharmaceuticals, Inc. all-time high annual retained earnings is -$39.82M

What is ARS Pharmaceuticals, Inc. annual retained earnings year-on-year change?

Over the past year, SPRY annual retained earnings has changed by +$8.00M (+6.09%)

What is ARS Pharmaceuticals, Inc. quarterly retained earnings?

The current quarterly retained earnings of SPRY is -$253.28M

What is the all-time high quarterly retained earnings for ARS Pharmaceuticals, Inc.?

ARS Pharmaceuticals, Inc. all-time high quarterly retained earnings is -$63.79M

What is ARS Pharmaceuticals, Inc. quarterly retained earnings year-on-year change?

Over the past year, SPRY quarterly retained earnings has changed by -$80.04M (-46.20%)
On this page